ArticleFrontiers in bioengineering and biotechnology2018
Recovering the Original Intentions of Risk Assessment and Management of Genetically Modified Organisms in the European Union.
Article in Frontiers in bioengineering and biotechnology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Overcoming Obstacles to Gene-Edited Solutions to Climate Challenges.Cold Spring Harbor perspectives in biology · 2024Review
- Current Techniques to Study Beneficial Plant-Microbe Interactions.Microorganisms · 2022Review
- Transcriptome Analysis ofInternational journal of molecular sciences · 2022Article
- Should we still worry about the safety of GMO foods? Why and why not? A review.Food science & nutrition · 2021Review
- The evolving EU regulatory framework for precision breeding.TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik · 2019Article
- Roads Forward for European GMO Policy-Uncertainties in Wake of ECJ Judgment Have to be Mitigated by Regulatory Reform.Frontiers in bioengineering and biotechnology · 2019Article
- When Policy Meets Practice: The Dilemma for Guidance on Risk Assessment Under the Cartagena Protocol on Biosafety.Frontiers in bioengineering and biotechnology · 2019Article
- A Welcome Proposal to Amend the GMO Legislation of the EU.Trends in biotechnology · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.